360 related articles for article (PubMed ID: 19996299)
1. Pharmacological blockade of the DP2 receptor inhibits cigarette smoke-induced inflammation, mucus cell metaplasia, and epithelial hyperplasia in the mouse lung.
Stebbins KJ; Broadhead AR; Baccei CS; Scott JM; Truong YP; Coate H; Stock NS; Santini AM; Fagan P; Prodanovich P; Bain G; Stearns BA; King CD; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
J Pharmacol Exp Ther; 2010 Mar; 332(3):764-75. PubMed ID: 19996299
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation.
Stebbins KJ; Broadhead AR; Correa LD; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
Eur J Pharmacol; 2010 Jul; 638(1-3):142-9. PubMed ID: 20447387
[TBL] [Abstract][Full Text] [Related]
3. DP2 (CRTh2) antagonism reduces ocular inflammation induced by allergen challenge and respiratory syncytial virus.
Stebbins KJ; Broadhead AR; Musiyenko A; Barik S; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
Int Arch Allergy Immunol; 2012; 157(3):259-68. PubMed ID: 22042170
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of AM211, a potent and selective prostaglandin D2 receptor type 2 antagonist that is active in animal models of allergic inflammation.
Bain G; Lorrain DS; Stebbins KJ; Broadhead AR; Santini AM; Prodanovich P; Darlington J; King CD; Lee C; Baccei C; Stearns B; Troung Y; Hutchinson JH; Prasit P; Evans JF
J Pharmacol Exp Ther; 2011 Jul; 338(1):290-301. PubMed ID: 21487069
[TBL] [Abstract][Full Text] [Related]
5. Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats.
Almishri W; Cossette C; Rokach J; Martin JG; Hamid Q; Powell WS
J Pharmacol Exp Ther; 2005 Apr; 313(1):64-9. PubMed ID: 15590767
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
9. Smoke induced changes in epithelial cell gene expression: development of an in vitro model for COPD.
Puljic R; Pahl A
ALTEX; 2004; 21(1):3-7. PubMed ID: 14976583
[TBL] [Abstract][Full Text] [Related]
10. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
Maestrelli P; Saetta M; Mapp CE; Fabbri LM
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2.
Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A
J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884
[TBL] [Abstract][Full Text] [Related]
12. Non-allergic models of mucous cell metaplasia and mucus hypersecretion in rat nasal and pulmonary airways.
Harkema JR; Wagner JG
Novartis Found Symp; 2002; 248():181-97; discussion 197-200, 277-82. PubMed ID: 12568495
[TBL] [Abstract][Full Text] [Related]
13. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
14. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils.
Royer JF; Schratl P; Carrillo JJ; Jupp R; Barker J; Weyman-Jones C; Beri R; Sargent C; Schmidt JA; Lang-Loidolt D; Heinemann A
Eur J Clin Invest; 2008 Sep; 38(9):663-71. PubMed ID: 18837743
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of liquiritin apioside on cigarette smoke-induced lung epithelial cell injury.
Guan Y; Li FF; Hong L; Yan XF; Tan GL; He JS; Dong XW; Bao MJ; Xie QM
Fundam Clin Pharmacol; 2012 Aug; 26(4):473-83. PubMed ID: 21631586
[TBL] [Abstract][Full Text] [Related]
16. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.
Monneret G; Cossette C; Gravel S; Rokach J; Powell WS
J Pharmacol Exp Ther; 2003 Jan; 304(1):349-55. PubMed ID: 12490611
[TBL] [Abstract][Full Text] [Related]
17. The role of ChemR23 in the induction and resolution of cigarette smoke-induced inflammation.
Demoor T; Bracke KR; Dupont LL; Plantinga M; Bondue B; Roy MO; Lannoy V; Lambrecht BN; Brusselle GG; Joos GF
J Immunol; 2011 May; 186(9):5457-67. PubMed ID: 21430224
[TBL] [Abstract][Full Text] [Related]
18. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
[TBL] [Abstract][Full Text] [Related]
19. A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep.
Shichijo M; Arimura A; Hirano Y; Yasui K; Suzuki N; Deguchi M; Abraham WM
Clin Exp Allergy; 2009 Sep; 39(9):1404-14. PubMed ID: 19486034
[TBL] [Abstract][Full Text] [Related]
20. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
Ishikawa Y; Yoshimoto T; Nakanishi K
Int Immunol; 2006 Jun; 18(6):847-55. PubMed ID: 16611648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
